0.440
0.01 (1.15%)
| Previous Close | 0.435 |
| Open | 0.425 |
| Volume | 63,600 |
| Avg. Volume (3M) | 125,395 |
| Market Cap | 766,428,224 |
| Price / Sales | 2.15 |
| Price / Book | 0.910 |
| 52 Weeks Range | |
| TTM Dividend Yield | 5.00% |
| Profit Margin | 0.68% |
| Operating Margin (TTM) | 1.71% |
| Diluted EPS (TTM) | -2.18 |
| Quarterly Revenue Growth (YOY) | 4.40% |
| Quarterly Earnings Growth (YOY) | -92.30% |
| Total Debt/Equity (MRQ) | 22.25% |
| Current Ratio (MRQ) | 1.87 |
| Operating Cash Flow (TTM) | 20.88 M |
| Levered Free Cash Flow (TTM) | -19.75 M |
| Return on Assets (TTM) | 0.49% |
| Return on Equity (TTM) | 0.25% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (MY) | Bullish | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | TMCLIFE | - | - |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 2.0 |
| Average | 1.63 |
|
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 82.36% |
| % Held by Institutions | 0.73% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 17 Nov 2025 | TheEdge | The Week Ahead: Focus on October trade, inflation data and campaigning in Sabah Election |
| TTM Dividend Yield | 5.00% |
| 5Y Average Dividend Yield | 0.60% |
| Payout Ratio | 66.19% |
| Expected Next Dividend Payment | Jan 2027 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 08 Dec 2025 | 26 Aug 2025 | 06 Jan 2026 | 0.0018 Cash |
| 05 Dec 2024 | 21 Aug 2024 | 03 Jan 2025 | 0.0172 Cash |
| 05 Dec 2024 | 21 Aug 2024 | 03 Jan 2025 | 0.0048 Cash |
| 05 Dec 2023 | 22 Aug 2023 | 03 Jan 2024 | 0.0041 Cash |
| 05 Dec 2023 | 22 Aug 2023 | 03 Jan 2024 | 0.0041 Cash |
| 05 Dec 2022 | 23 Aug 2022 | 03 Jan 2023 | 0.0027 Cash |
| 06 Dec 2021 | 02 Dec 2021 | 03 Jan 2022 | 0.0022 Cash |
| 04 Dec 2020 | 25 Aug 2020 | 04 Jan 2021 | 0.0017 Cash |
| 06 Mar 2020 | 18 Dec 2019 | 25 Mar 2020 | 0.002 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2025 | 0.022 | 2 | 5.00 |
| 2024 | 0.008 | 2 | 1.64 |
| 2023 | 0.003 | 1 | 0.38 |
| 2022 | 0.002 | 1 | 0.35 |
| 2021 | 0.002 | 1 | 0.32 |
| 2020 | 0.002 | 1 | 0.30 |
| Show more | |||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |